Antisense modulation of interferon gamma receptor 2 expression

Details Antisense modulation of interferon gamma receptor 2 expression Antisense modulation of interferon gamma receptor 2 expression

2005-03-22

2005-03-22

Nguyen, Dave Trong (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C514S04400A

Reexamination Certificate

active

06870046

ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of Interferon gamma receptor 2. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Interferon gamma receptor 2. Methods of using these compounds for modulation of Interferon gamma receptor 2 expression and for treatment of diseases associated with expression of Interferon gamma receptor 2 are provided.

REFERENCES:
patent: 6043090 (2000-03-01), Monia et al.
patent: WO 9715674 (1997-05-01), None
patent: WO 9951766 (1999-10-01), None
Soh et al. Cell (1994) vol. 76:793-802.*
Kardassis et al., “Transactivation of the Human Apoplipoprotein CII Promoter by Orphan and Ligand-dependent Nuclear Receptors”, J. Biol. Chem. 1998 273(2B):17810-17816.
Marra et al., “Interferon-γ-Mediated Activation of STAT1α Regulates Growth Factor-Induced Mitogenesis”, J. Clin. Invest. 1996 98:1218-1230.
Ochiai et al., “The Role of STAT1 in Activation of IL-3-and IL-5-Induced Eosinophils by Interferon Gamma”, Int Arch Allergy Immunol 2001 124:237-241.
Billiau, Interferon-gamma: biology and role in pathogenesis,Adv. Immunol.,1996, 62:61-130.
Biswas et al., Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells,J. Exp. Med.,1992, 176:739-750.
Cook et al., Sublocalization of the human interferon-gamma receptor accessory factor gene and characterization of accessory factor activity by yeast artificial chromosomal fragmentation,J Biol Chem,1994, 269:7013-7018.
Dorman et al., Interferon-gamma and interleukin-12 pathway defects and human disease,Cytokine Growth Factor Rev.,2000, 11:321-333.
Fais et al., Interferon expression in Crohn's disease patients: increased interferon-gamma and -alpha mRNA in the intestinal lamina propria mononuclear cells,J. Interferon Res.,1994, 14:235-238.
Ferrantini et al., INF-alpha 1 gene expression into a metastatic murine adenocarcinoma (TS/A) results in CDB+T Cell-mediated tumor rejection and development of antitumor immunity. Comparative studies with IFN-gamma-producing TS/A cells,J. Immunol.,1994, 153:4604-4615.
Gansbacher et al., Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity,Cancer Res.,1990, 50:7820-7825.
Novelli et al., Environmental signals influencing expression of the IFN-gamma receptor on human T cells control whether IFN-gamma promotes proliferation or apoptosis,J. Immunol.,1994, 152:496-504.
Townsend et al., Unravelling the net ? cytokines and diseases,J. Cell Sci.,2000, 113:3549-3550.

Affiliated with

Also associated with

Rating

Antisense modulation of interferon gamma receptor 2 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antisense modulation of interferon gamma receptor 2 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of interferon gamma receptor 2 expression will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3416646